AHAndrés Herrán

Andrés Herrán

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Andrés Herrán has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Neuroticism does not influence the relationships between tobacco and panic features in the early phases of panic disorder

    by B. Rodriguez-Cabo, A. Herran, M.L. Ramirez, M. Carrera, F. Hoyuela, O. Fernandez-Torre, A. Ayestaran, D. Sierra-Biddle, J.L. Vazquez-Barquero

  • Lipoprotein a levels in recent onset panic disorder. Relationship with clinical severity and treatment response

    by O. Fernández-Torre, A. Herrán, M.T. García-Unzueta, M.L. Ramírez, B. Rodríguez-Cabo, F. Hoyuela, M. Carrera, A. Ayestarán, J.L. Vázquez-Barquero, J.A. Amado

  • Open Access

    Effects of long-term treatment with antipsychotics on serum leptin levels

    by Andrés Herrán, María Teresa García-Unzueta, José Antonio Amado, María Teresa De La Maza, Concepción Álvarez, José Luis Vázquez-Barquero

    Background: Abnormal regulation of the adipocyte-derived hormone leptin could play a role in body weight gain induced by antipsychotics.Aims: To study the effects of long-term antipsychotic treatment on leptin levels in patients with schizophrenia.Method: Serum leptin levels were determined in 59 out-patients with chronic schizophrenia and in the same number of healthy subjects controlled by gender, age and body mass index.Results: Leptin levels did not differ between patients and controls. Leptin levels in patients with schizophrenia correlated with weight gain, even after controlling for current weight, but did not show any association with clinical variables. Antipsychotic class tended to exert different effects over leptin levels (among atypicals, olanzapine induced a greater increase).Conclusions: Elevation of leptin levels induced by chronic antipsychotic treatment can be attributed to weight gain, but other mechanisms could be involved.


  • Diagnostic Accuracy in the First 5 minof a Psychiatric Interview

    by Andrés Herrán, Deirdre Sierra-Biddle, Ana de Santiago, Jesús Artal, Juan Francisco Díez-Manrique, José Luis Vázquez-Barquero

    Background: There is little if any research on the explicit contents delivered by patients in the first minutes of a psychiatric interview. Methods: In order to study the impact of the first minutes of a psychiatric interview on final diagnosis, we gathered information from the speech during the first 5 min in 162 new psychiatric patients with a checklist including symptoms extracted from the SCAN interview. Results: The area reported most frequently was life events (51.2%). The average of psychiatric symptoms cited was 2.3. An initial suspected diagnosis was done in 126 patients, and in 73 patients (57.9% of those with a suspected diagnosis, 45.1% of the total sample) the initial diagnosis was coincident with the final diagnosis. The initial clinical impression was more accurate in adjustment and ‘neurotic’ disorders, and less in mood disorders. Those patients who cited more symptoms received a less accurate initial diagnosis. Conclusion: Psychiatric patients spontaneously report a low number of symptoms. The accuracy of psychiatric diagnosis in the first minutes of an interview is unacceptably low. However, the role of short psychiatric interviewing as a screening method deserves to be further investigated.


  • Increased Bone Remodeling in First-Episode Major Depressive Disorder

    by Andrés Herrán, José Antonio Amado, María Teresa García-Unzueta, José Luis Vázquez-Barquero, Lorena Perera, Jesús González-Macías

    Bone mineral density is decreased in patients with depressive disorder. This study evaluated biochemical bone remodeling markers in patients having their first depressive episode who had not taken psychotropic medications to evaluate possible pathogenic mechanisms implicated in the loss of bone mineral density in early states of this illness. Serum osteocalcin, parathyroid hormone, bone alkaline phosphatase, telopeptide, collagen type I C-terminal propeptide, cross-laps, and 25-hydroxyvitamin D levels were measured in 19 depressive patients and 19 age-matched healthy women. In addition, serum cortisol and interleukin-6 were determined. Patients were assessed with the Schedules for Clinical Assessment in Neuropsychiatry interview and met criteria for a single depressive episode. Depressed patients had increased levels of osteocalcin (p = .003), an osteoblastic marker; telopeptide (p = .01), an osteoclastic marker; and cross-laps (p = .000), another osteoclastic marker. Parathyroid hormone was lower in patients (p = .02), whereas the rest of the markers were comparable between patients and healthy control subjects. Serum cortisol was higher in depressed patients than in control subjects (p = .003), but cortisolemia and interleukin-6 did not show any relationship with bone markers in patients. Clinical severity of the illness and weight loss due to depression in patients did not correlate with bone remodeling markers. These data suggest that an increase in bone remodeling not due to vitamin D deficiency induces a release of calcium from bone and inhibition of parathyroid hormone secretion.


    • 11 August 2000
      • Vol. 28  (2) , 77-87

    [Spanish version of the new World Health Organization Disability Assessment Schedule II (WHO-DAS-II): initial phase of development and pilot study. Cantabria disability work group].

    by J L Vázquez-Barquero, E Vázquez Bourgón, S Herrera Castanedo, J Saiz, M Uriarte, F Morales, L Gaite, A Herrán, T B Ustün

    The aim of the present paper is to present the initial phases of the development of the Spanish version of the "World Health Organization Disablement Assessment Schedule II" WHO-DAS-II and also to describe the quantitative and qualitative methodological strategies used in the elaboration process of an instrument: i) compatible with the new International Classification of Functioning and Disability -ICIDH-2- of the World Health Organisation; ii) with criteria of cross-cultural applicability and; iii) to allow us to assess the disability in all its dimensions.


    • 12 April 2000
      • Vol. 28  (1) , 13-21

    [Referral of patients with mental disorders from primary care to mental health units].

    by A Herrán, J R López-Lanza, H Ganzo, A Cadiñanos, J F Díez-Manrique, J Vázquez-Barquero

    Most part of the patients suffering from mental disorders are treated by non-psychiatrist physicians, mainly by general practitioners (GPs). The aim of this study has been to analyse the factors influencing the referral of patients with mental illness to psychiatric services. Using data of referrals from two Primary Care Centres (population: 28.039) to a Mental Health Unit in one year period, we analysed clinical records, information provided with the referral, and the opinion of GPs about mental illness. Out of the 486 referrals, the 153 patients without previous consultations were included in the analysis. Men, and those with higher educational status were referred more frequently. A 34% of the referrals included information about psychopathological symptoms, and 70% included clinical diagnosis. Primary care physicians specialised in family medicine included more data regarding psychopathological symptoms, and included a specific request more often than GPs without specialised training. Diagnostic accuracy (61%) were lower for adjustment and personality disorders, and in those patients with an urgent referral. Patients with an urgent referral did not present different clinical features, nor different severity than those with an ordinary referral. Management of patients with mental disorders in PHC should be improved with guidelines about treatment and referral. Different levels of care should be co-ordinated.


  • Higher levels of serum copper in schizophrenic patients treated with depot neuroleptics

    by Andrés Herrán, María Teresa García-Unzueta, María Dolores Fernández-González, José Luis Vázquez-Barquero, Concepción Alvarez, Jose Antonio Amado


  • Determinants of smoking behaviour in outpatients with schizophrenia

    by André Herrán, Ana de Santiago, Marta Sandoya, Marı́a J Fernández, Juan Francisco Dı́eZ-Manrique, José Luis Vázquez-Barquero


  • Folate levels in psychiatric outpatients

    by A. Herrán, M. T. García‐Unzueta, J. A. Amado, J. J. López‐Cordovilla, J. F. Díez‐Manrique, J. L. Vázquez‐Barquero

    This study examines folate in psychiatric outpatients. Fifty‐three outpatients with schizophrenia and 24 outpatients with depressive disorder assessed with the Schedules for Clinical Assessment in Neuropsychiatry interview are included. Patients with schizophrenia had lower serum folate levels than age‐ and sex‐matched controls, while red cell folate levels did not differ. Serum folate levels showed a negative correlation with the Clinical Global Impression, disorganized dimension, and total Positive and Negative Syndrome Scale score. Patients with depressive disorder had lower serum folate levels than healthy controls, but showed no differences in red cell folate levels. Only two patients with schizophrenia had red cell folate levels below the normal range.